Ramoni, Davide
Tirandi, Amedeo
Montecucco, Fabrizio
Liberale, Luca http://orcid.org/0000-0003-1472-7975
Funding for this research was provided by:
Università degli Studi di Genova
Article History
Received: 26 September 2023
Accepted: 17 December 2023
First Online: 31 January 2024
Declaration
:
: LL is co-inventor on the International Patent WO/2020/226993 filed in April 2020. The patent relates to the use of antibodies which specifically bind IL-1α to reduce various sequelae of ischemia–reperfusion injury to the central nervous system. LL reports speaker fees outside of this work from Daiichi-Sankyo. FM received a round table fee from Astra Zeneca. The other authors have no direct financial or personal interests to declare.
: This is a review article, as it does not include animal or human data this is not necessary.